Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares - Yahoo Finance

Certara Inc (NASDAQ:CERT), a global leader in biosimulation, provides software, consulting, and technology-enabled services to support drug discovery, development, and regulatory science. The company's solutions are used by biopharmaceutical companies, academic institutions, and regulatory agencies worldwide to bring therapies to patients more efficiently.According to a recent SEC Filing, Patrick Smith, President of Drug Development Solutions at Certara Inc (NASDAQ:CERT), sold 14,427 shares of the company on April 2, 2024. The transaction was executed at an average price of $16.85 per share, resulting in a total value of $243,095. The insider's sale has been recorded amidst a backdrop of insider trading activity at the company.Over the past year, the insider, Patrick Smith, has sold a total of 38,531 ...

Yahoo     Apr 04, 2024